Central nervous system: Dizziness.
Dermatologic: Dermatological reaction (includes edema, urticarial rash), pruritus.
Gastrointestinal: Diarrhea, nausea.
Hematologic & oncologic: Decreased white blood cell count, eosinophilia, increased hemoglobin.
Hepatic: Increased serum ALT, increased serum AST.
Rare but important or life-threatening: Abdominal distension, abdominal pain, abnormal gait, abnormal sensation in eyes, anemia, anorexia, anterior uveitis, ataxia, back pain, chest discomfort, chorioretinitis, coma, confusion, conjunctivitis, constipation, drowsiness, dyspnea, exacerbation of asthma, eye redness, eyelid edema, fatigue, fecal incontinence, headache, hepatitis, hypotension, increased serum bilirubin, keratitis, lethargy, leukopenia, mental status changes, myalgia, neck pain, posterior uveitis, seizure, skin rash, Stevens-Johnson syndrome, stupor, temporary vision loss, toxic epidermal necrolysis, tremor, urinary incontinence, urticaria, vertigo, vomiting, weakness.
View ADR Reporting Link